Interventional Cardiology Devices Size, Share, Growth Analysis, By Product (Coronary Stents, Structural Heart Devices), By End User (Hospitals & ASCS, Catheterization Labs & Others), By Region - Industry Forecast 2025-2032

North America is expected to lead the global interventional cardiology devices market throughout the forecast period due to the influence of advanced healthcare infrastructure, supportive government product development initiatives, and high patient awareness levels. According to the American Heart Association, by 2035, approximately 45% of the US population will be affected by heart disease as a result of factors such as high obesity, high smoking, and unhealthy lifestyles, which can cause a heart attack and other related issues. In addition, 1.5 million Americans are treated for diabetes each year in the United States alone. Incidence of diabetes is increasing primarily due to an increase in the geriatric population; it is guesstimated that 25% of all geriatric individuals (aged 60 and above) in the United States have diabetes.

Because of prevalence of overweight and changing lifestyle habits such as dietary irregularities, as well as an increasing number of global smokers, the United Kingdom in Europe is expected to hold the second-largest interventional cardiology devices market share.

Due to the increasing elderly and pediatric population, which is more likely to be exposed to coronary artery disease, Asia-Pacific is anticipated to emerge as the fastest growing region in the market during the forecast period. The convenience provided by these devices is driving Asia-Pacific market growth. Furthermore, increasing medical investment has contributed to the expansion of the regional market.